nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.035	0.0473	CbGbCtD
Hydrocortisone—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.034	0.046	CbGbCtD
Hydrocortisone—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0308	0.0416	CbGbCtD
Hydrocortisone—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0308	0.0416	CbGbCtD
Hydrocortisone—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0255	0.0344	CbGbCtD
Hydrocortisone—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.023	0.0312	CbGbCtD
Hydrocortisone—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.023	0.0312	CbGbCtD
Hydrocortisone—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0225	0.0304	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0225	0.0304	CbGbCtD
Hydrocortisone—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0221	0.0299	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0194	0.0262	CbGbCtD
Hydrocortisone—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0194	0.0262	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0188	0.0254	CbGbCtD
Hydrocortisone—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0188	0.0254	CbGbCtD
Hydrocortisone—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0186	0.0252	CbGbCtD
Hydrocortisone—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0171	0.0231	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.017	0.023	CbGbCtD
Hydrocortisone—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.017	0.023	CbGbCtD
Hydrocortisone—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.017	0.023	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.017	0.023	CbGbCtD
Hydrocortisone—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0168	0.0228	CbGbCtD
Hydrocortisone—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0168	0.0228	CbGbCtD
Hydrocortisone—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0162	0.0219	CbGbCtD
Hydrocortisone—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0162	0.0219	CbGbCtD
Hydrocortisone—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0145	0.0197	CbGbCtD
Hydrocortisone—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0141	0.0191	CbGbCtD
Hydrocortisone—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0128	0.0173	CbGbCtD
Hydrocortisone—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0128	0.0173	CbGbCtD
Hydrocortisone—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0123	0.0166	CbGbCtD
Hydrocortisone—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0123	0.0166	CbGbCtD
Hydrocortisone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0121	0.0164	CbGbCtD
Hydrocortisone—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0118	0.0159	CbGbCtD
Hydrocortisone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.011	0.0148	CbGbCtD
Hydrocortisone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00947	0.0128	CbGbCtD
Hydrocortisone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00919	0.0124	CbGbCtD
Hydrocortisone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00831	0.0112	CbGbCtD
Hydrocortisone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00831	0.0112	CbGbCtD
Hydrocortisone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00797	0.0108	CbGbCtD
Hydrocortisone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00773	0.0104	CbGbCtD
Hydrocortisone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00726	0.00982	CbGbCtD
Hydrocortisone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00726	0.00982	CbGbCtD
Hydrocortisone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00657	0.00888	CbGbCtD
Hydrocortisone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00657	0.00888	CbGbCtD
Hydrocortisone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00616	0.00833	CbGbCtD
Hydrocortisone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00567	0.00767	CbGbCtD
Hydrocortisone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00551	0.00744	CbGbCtD
Hydrocortisone—SHBG—semen—acquired immunodeficiency syndrome	0.00499	0.0918	CbGeAlD
Hydrocortisone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00498	0.00673	CbGbCtD
Hydrocortisone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00498	0.00673	CbGbCtD
Hydrocortisone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00477	0.00645	CbGbCtD
Hydrocortisone—CYP11B2—blood plasma—acquired immunodeficiency syndrome	0.00399	0.0734	CbGeAlD
Hydrocortisone—ANXA1—nerve—acquired immunodeficiency syndrome	0.0036	0.0662	CbGeAlD
Hydrocortisone—ANXA1—blood plasma—acquired immunodeficiency syndrome	0.00272	0.0501	CbGeAlD
Hydrocortisone—SHBG—blood plasma—acquired immunodeficiency syndrome	0.00182	0.0334	CbGeAlD
Hydrocortisone—CYP11B1—blood—acquired immunodeficiency syndrome	0.00146	0.0269	CbGeAlD
Hydrocortisone—CYP11B2—blood—acquired immunodeficiency syndrome	0.00146	0.0269	CbGeAlD
Hydrocortisone—ANXA1—skin of body—acquired immunodeficiency syndrome	0.00131	0.0241	CbGeAlD
Hydrocortisone—NR3C1—nerve—acquired immunodeficiency syndrome	0.00125	0.023	CbGeAlD
Hydrocortisone—ANXA1—lymphoid tissue—acquired immunodeficiency syndrome	0.00106	0.0195	CbGeAlD
Hydrocortisone—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0194	CbGeAlD
Hydrocortisone—ANXA1—digestive system—acquired immunodeficiency syndrome	0.00105	0.0192	CbGeAlD
Hydrocortisone—ANXA1—blood—acquired immunodeficiency syndrome	0.000996	0.0183	CbGeAlD
Hydrocortisone—ANXA1—bone marrow—acquired immunodeficiency syndrome	0.000964	0.0177	CbGeAlD
Hydrocortisone—ANXA1—spinal cord—acquired immunodeficiency syndrome	0.00096	0.0177	CbGeAlD
Hydrocortisone—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000952	0.0175	CbGeAlD
Hydrocortisone—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.000944	0.0174	CbGeAlD
Hydrocortisone—ANXA1—vagina—acquired immunodeficiency syndrome	0.000923	0.017	CbGeAlD
Hydrocortisone—CYP11B2—lymph node—acquired immunodeficiency syndrome	0.000876	0.0161	CbGeAlD
Hydrocortisone—ANXA1—lung—acquired immunodeficiency syndrome	0.000873	0.0161	CbGeAlD
Hydrocortisone—ANXA1—nervous system—acquired immunodeficiency syndrome	0.000809	0.0149	CbGeAlD
Hydrocortisone—ANXA1—central nervous system—acquired immunodeficiency syndrome	0.000779	0.0143	CbGeAlD
Hydrocortisone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000714	0.0131	CbGeAlD
Hydrocortisone—SHBG—blood—acquired immunodeficiency syndrome	0.000666	0.0123	CbGeAlD
Hydrocortisone—SHBG—bone marrow—acquired immunodeficiency syndrome	0.000644	0.0119	CbGeAlD
Hydrocortisone—ANXA1—brain—acquired immunodeficiency syndrome	0.000618	0.0114	CbGeAlD
Hydrocortisone—SHBG—vagina—acquired immunodeficiency syndrome	0.000617	0.0114	CbGeAlD
Hydrocortisone—ANXA1—lymph node—acquired immunodeficiency syndrome	0.000597	0.011	CbGeAlD
Hydrocortisone—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.00058	0.0107	CbGeAlD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000536	0.044	CbGpPWpGaD
Hydrocortisone—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000533	0.00981	CbGeAlD
Hydrocortisone—SHBG—central nervous system—acquired immunodeficiency syndrome	0.00052	0.00958	CbGeAlD
Hydrocortisone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000506	0.00931	CbGeAlD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000486	0.0399	CbGpPWpGaD
Hydrocortisone—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000485	0.00892	CbGeAlD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.000459	0.0377	CbGpPWpGaD
Hydrocortisone—NR3C1—skin of body—acquired immunodeficiency syndrome	0.000454	0.00836	CbGeAlD
Hydrocortisone—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000449	0.00826	CbGeAlD
Hydrocortisone—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000432	0.00796	CbGeAlD
Hydrocortisone—SHBG—brain—acquired immunodeficiency syndrome	0.000413	0.0076	CbGeAlD
Hydrocortisone—CYP2C8—blood—acquired immunodeficiency syndrome	0.000386	0.00711	CbGeAlD
Hydrocortisone—ABCG2—blood—acquired immunodeficiency syndrome	0.000376	0.00692	CbGeAlD
Hydrocortisone—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.000368	0.00677	CbGeAlD
Hydrocortisone—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000366	0.00674	CbGeAlD
Hydrocortisone—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000363	0.00669	CbGeAlD
Hydrocortisone—NR3C1—digestive system—acquired immunodeficiency syndrome	0.000363	0.00669	CbGeAlD
Hydrocortisone—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000362	0.00666	CbGeAlD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000359	0.0295	CbGpPWpGaD
Hydrocortisone—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000358	0.00659	CbGeAlD
Hydrocortisone—CYP3A5—blood—acquired immunodeficiency syndrome	0.000349	0.00642	CbGeAlD
Hydrocortisone—ABCG2—vagina—acquired immunodeficiency syndrome	0.000348	0.00641	CbGeAlD
Hydrocortisone—NR3C1—blood—acquired immunodeficiency syndrome	0.000346	0.00637	CbGeAlD
Hydrocortisone—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000343	0.00632	CbGeAlD
Hydrocortisone—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.000335	0.00616	CbGeAlD
Hydrocortisone—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.000333	0.00614	CbGeAlD
Hydrocortisone—ABCG2—lung—acquired immunodeficiency syndrome	0.000329	0.00606	CbGeAlD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000325	0.0267	CbGpPWpGaD
Hydrocortisone—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000323	0.00595	CbGeAlD
Hydrocortisone—SLCO1A2—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000323	0.0265	CbGpPWpGaD
Hydrocortisone—NR3C1—vagina—acquired immunodeficiency syndrome	0.000321	0.0059	CbGeAlD
Hydrocortisone—CYP3A5—lung—acquired immunodeficiency syndrome	0.000306	0.00563	CbGeAlD
Hydrocortisone—NR3C1—lung—acquired immunodeficiency syndrome	0.000303	0.00558	CbGeAlD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000294	0.0241	CbGpPWpGaD
Hydrocortisone—NR3C1—nervous system—acquired immunodeficiency syndrome	0.000281	0.00517	CbGeAlD
Hydrocortisone—ABCB1—retina—acquired immunodeficiency syndrome	0.000277	0.0051	CbGeAlD
Hydrocortisone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000275	0.00506	CbGeAlD
Hydrocortisone—ANXA1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000274	0.0225	CbGpPWpGaD
Hydrocortisone—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.00027	0.00498	CbGeAlD
Hydrocortisone—ANXA1—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000265	0.0218	CbGpPWpGaD
Hydrocortisone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000262	0.00482	CbGeAlD
Hydrocortisone—CYP2C8—brain—acquired immunodeficiency syndrome	0.00024	0.00441	CbGeAlD
Hydrocortisone—SLCO1A2—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000239	0.0196	CbGpPWpGaD
Hydrocortisone—ABCG2—brain—acquired immunodeficiency syndrome	0.000233	0.00429	CbGeAlD
Hydrocortisone—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000225	0.00415	CbGeAlD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000218	0.0179	CbGpPWpGaD
Hydrocortisone—NR3C1—brain—acquired immunodeficiency syndrome	0.000215	0.00395	CbGeAlD
Hydrocortisone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000212	0.00391	CbGeAlD
Hydrocortisone—NR3C1—lymph node—acquired immunodeficiency syndrome	0.000207	0.00382	CbGeAlD
Hydrocortisone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000205	0.00377	CbGeAlD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000201	0.0165	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000197	0.0162	CbGpPWpGaD
Hydrocortisone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000197	0.00362	CbGeAlD
Hydrocortisone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000194	0.00358	CbGeAlD
Hydrocortisone—ABCB1—blood—acquired immunodeficiency syndrome	0.000185	0.00341	CbGeAlD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000184	0.0151	CbGpPWpGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000181	0.0149	CbGpPWpGaD
Hydrocortisone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000179	0.0033	CbGeAlD
Hydrocortisone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000178	0.00329	CbGeAlD
Hydrocortisone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000172	0.00316	CbGeAlD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00017	0.014	CbGpPWpGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00017	0.014	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000166	0.0136	CbGpPWpGaD
Hydrocortisone—ABCB1—lung—acquired immunodeficiency syndrome	0.000162	0.00299	CbGeAlD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000153	0.0126	CbGpPWpGaD
Hydrocortisone—ABCB1—nervous system—acquired immunodeficiency syndrome	0.00015	0.00277	CbGeAlD
Hydrocortisone—ANXA1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00015	0.0123	CbGpPWpGaD
Hydrocortisone—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000145	0.00267	CbGeAlD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000144	0.0118	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000144	0.0118	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00014	0.0115	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000134	0.011	CbGpPWpGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00013	0.0107	CbGpPWpGaD
Hydrocortisone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000659	CcSEcCtD
Hydrocortisone—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000657	CcSEcCtD
Hydrocortisone—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000657	CcSEcCtD
Hydrocortisone—Rash—Didanosine—acquired immunodeficiency syndrome	0.000127	0.000655	CcSEcCtD
Hydrocortisone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000655	CcSEcCtD
Hydrocortisone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000655	CcSEcCtD
Hydrocortisone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000127	0.000655	CcSEcCtD
Hydrocortisone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000127	0.000655	CcSEcCtD
Hydrocortisone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000126	0.000651	CcSEcCtD
Hydrocortisone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000126	0.00065	CcSEcCtD
Hydrocortisone—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000649	CcSEcCtD
Hydrocortisone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000649	CcSEcCtD
Hydrocortisone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000125	0.000648	CcSEcCtD
Hydrocortisone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000647	CcSEcCtD
Hydrocortisone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000125	0.000646	CcSEcCtD
Hydrocortisone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000646	CcSEcCtD
Hydrocortisone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000645	CcSEcCtD
Hydrocortisone—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000125	0.0103	CbGpPWpGaD
Hydrocortisone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000645	CcSEcCtD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000125	0.0102	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000125	0.0102	CbGpPWpGaD
Hydrocortisone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000644	CcSEcCtD
Hydrocortisone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000642	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000641	CcSEcCtD
Hydrocortisone—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000641	CcSEcCtD
Hydrocortisone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000124	0.00064	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000124	0.0102	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000124	0.00064	CcSEcCtD
Hydrocortisone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000124	0.000639	CcSEcCtD
Hydrocortisone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000124	0.000638	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000638	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000637	CcSEcCtD
Hydrocortisone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000636	CcSEcCtD
Hydrocortisone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000123	0.000634	CcSEcCtD
Hydrocortisone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000634	CcSEcCtD
Hydrocortisone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000632	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000632	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000122	0.00063	CcSEcCtD
Hydrocortisone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000122	0.000629	CcSEcCtD
Hydrocortisone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000629	CcSEcCtD
Hydrocortisone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000629	CcSEcCtD
Hydrocortisone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000629	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000628	CcSEcCtD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000122	0.00999	CbGpPWpGaD
Hydrocortisone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000627	CcSEcCtD
Hydrocortisone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000624	CcSEcCtD
Hydrocortisone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000623	CcSEcCtD
Hydrocortisone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.000623	CcSEcCtD
Hydrocortisone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000623	CcSEcCtD
Hydrocortisone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000621	CcSEcCtD
Hydrocortisone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.00062	CcSEcCtD
Hydrocortisone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.00062	CcSEcCtD
Hydrocortisone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00012	0.000619	CcSEcCtD
Hydrocortisone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000619	CcSEcCtD
Hydrocortisone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000619	CcSEcCtD
Hydrocortisone—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.00012	0.00983	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00012	0.000617	CcSEcCtD
Hydrocortisone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00012	0.000617	CcSEcCtD
Hydrocortisone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000616	CcSEcCtD
Hydrocortisone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000616	CcSEcCtD
Hydrocortisone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000615	CcSEcCtD
Hydrocortisone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000612	CcSEcCtD
Hydrocortisone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.00061	CcSEcCtD
Hydrocortisone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.00061	CcSEcCtD
Hydrocortisone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000118	0.000608	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000608	CcSEcCtD
Hydrocortisone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000607	CcSEcCtD
Hydrocortisone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000605	CcSEcCtD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000117	0.0096	CbGpPWpGaD
Hydrocortisone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000603	CcSEcCtD
Hydrocortisone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000601	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000601	CcSEcCtD
Hydrocortisone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.0006	CcSEcCtD
Hydrocortisone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000599	CcSEcCtD
Hydrocortisone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.000599	CcSEcCtD
Hydrocortisone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000598	CcSEcCtD
Hydrocortisone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000116	0.000597	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000597	CcSEcCtD
Hydrocortisone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000596	CcSEcCtD
Hydrocortisone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000595	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000595	CcSEcCtD
Hydrocortisone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000594	CcSEcCtD
Hydrocortisone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000115	0.000594	CcSEcCtD
Hydrocortisone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000594	CcSEcCtD
Hydrocortisone—ABCB1—brain—acquired immunodeficiency syndrome	0.000115	0.00212	CbGeAlD
Hydrocortisone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000592	CcSEcCtD
Hydrocortisone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000592	CcSEcCtD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000114	0.00939	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000114	0.00939	CbGpPWpGaD
Hydrocortisone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.00059	CcSEcCtD
Hydrocortisone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000589	CcSEcCtD
Hydrocortisone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000114	0.000589	CcSEcCtD
Hydrocortisone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000114	0.000589	CcSEcCtD
Hydrocortisone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000114	0.000588	CcSEcCtD
Hydrocortisone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000587	CcSEcCtD
Hydrocortisone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000113	0.000586	CcSEcCtD
Hydrocortisone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000584	CcSEcCtD
Hydrocortisone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000583	CcSEcCtD
Hydrocortisone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000582	CcSEcCtD
Hydrocortisone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000581	CcSEcCtD
Hydrocortisone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000581	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.00058	CcSEcCtD
Hydrocortisone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000112	0.00058	CcSEcCtD
Hydrocortisone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000577	CcSEcCtD
Hydrocortisone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000577	CcSEcCtD
Hydrocortisone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000577	CcSEcCtD
Hydrocortisone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000577	CcSEcCtD
Hydrocortisone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000576	CcSEcCtD
Hydrocortisone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.000576	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000111	0.00914	CbGpPWpGaD
Hydrocortisone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000111	0.000574	CcSEcCtD
Hydrocortisone—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000111	0.00204	CbGeAlD
Hydrocortisone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000573	CcSEcCtD
Hydrocortisone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.000571	CcSEcCtD
Hydrocortisone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.00057	CcSEcCtD
Hydrocortisone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00057	CcSEcCtD
Hydrocortisone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.00057	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000569	CcSEcCtD
Hydrocortisone—Rash—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000569	CcSEcCtD
Hydrocortisone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000569	CcSEcCtD
Hydrocortisone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000569	CcSEcCtD
Hydrocortisone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000568	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000567	CcSEcCtD
Hydrocortisone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.000567	CcSEcCtD
Hydrocortisone—Headache—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000565	CcSEcCtD
Hydrocortisone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000109	0.000565	CcSEcCtD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000109	0.00899	CbGpPWpGaD
Hydrocortisone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000564	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000564	CcSEcCtD
Hydrocortisone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000563	CcSEcCtD
Hydrocortisone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000109	0.000561	CcSEcCtD
Hydrocortisone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000108	0.00056	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00056	CcSEcCtD
Hydrocortisone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00056	CcSEcCtD
Hydrocortisone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00056	CcSEcCtD
Hydrocortisone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000557	CcSEcCtD
Hydrocortisone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000556	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000556	CcSEcCtD
Hydrocortisone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000108	0.000555	CcSEcCtD
Hydrocortisone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000555	CcSEcCtD
Hydrocortisone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000552	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000107	0.00877	CbGpPWpGaD
Hydrocortisone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000551	CcSEcCtD
Hydrocortisone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000549	CcSEcCtD
Hydrocortisone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000548	CcSEcCtD
Hydrocortisone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000548	CcSEcCtD
Hydrocortisone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000548	CcSEcCtD
Hydrocortisone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000545	CcSEcCtD
Hydrocortisone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000545	CcSEcCtD
Hydrocortisone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000544	CcSEcCtD
Hydrocortisone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000543	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000541	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000539	CcSEcCtD
Hydrocortisone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.000538	CcSEcCtD
Hydrocortisone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000537	CcSEcCtD
Hydrocortisone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000537	CcSEcCtD
Hydrocortisone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000537	CcSEcCtD
Hydrocortisone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000104	0.000536	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000535	CcSEcCtD
Hydrocortisone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000534	CcSEcCtD
Hydrocortisone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000531	CcSEcCtD
Hydrocortisone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.00053	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000102	0.00841	CbGpPWpGaD
Hydrocortisone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000102	0.000528	CcSEcCtD
Hydrocortisone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000527	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000527	CcSEcCtD
Hydrocortisone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000526	CcSEcCtD
Hydrocortisone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000524	CcSEcCtD
Hydrocortisone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000523	CcSEcCtD
Hydrocortisone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000523	CcSEcCtD
Hydrocortisone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000522	CcSEcCtD
Hydrocortisone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000521	CcSEcCtD
Hydrocortisone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000521	CcSEcCtD
Hydrocortisone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.000519	CcSEcCtD
Hydrocortisone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000517	CcSEcCtD
Hydrocortisone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.0001	0.000516	CcSEcCtD
Hydrocortisone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.88e-05	0.00051	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	9.88e-05	0.00812	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.88e-05	0.00051	CcSEcCtD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	9.86e-05	0.0081	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.84e-05	0.000508	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.81e-05	0.000507	CcSEcCtD
Hydrocortisone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.000506	CcSEcCtD
Hydrocortisone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.8e-05	0.000506	CcSEcCtD
Hydrocortisone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.74e-05	0.000503	CcSEcCtD
Hydrocortisone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.73e-05	0.000503	CcSEcCtD
Hydrocortisone—Pain—Saquinavir—acquired immunodeficiency syndrome	9.72e-05	0.000502	CcSEcCtD
Hydrocortisone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.67e-05	0.000499	CcSEcCtD
Hydrocortisone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.66e-05	0.000499	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.66e-05	0.000499	CcSEcCtD
Hydrocortisone—Rash—Zidovudine—acquired immunodeficiency syndrome	9.58e-05	0.000495	CcSEcCtD
Hydrocortisone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.58e-05	0.000495	CcSEcCtD
Hydrocortisone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.57e-05	0.000494	CcSEcCtD
Hydrocortisone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.55e-05	0.000493	CcSEcCtD
Hydrocortisone—Headache—Zidovudine—acquired immunodeficiency syndrome	9.52e-05	0.000491	CcSEcCtD
Hydrocortisone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.44e-05	0.000488	CcSEcCtD
Hydrocortisone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.43e-05	0.000487	CcSEcCtD
Hydrocortisone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.41e-05	0.000486	CcSEcCtD
Hydrocortisone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.38e-05	0.000484	CcSEcCtD
Hydrocortisone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.37e-05	0.000484	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.36e-05	0.000483	CcSEcCtD
Hydrocortisone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.35e-05	0.000483	CcSEcCtD
Hydrocortisone—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.34e-05	0.000482	CcSEcCtD
Hydrocortisone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.34e-05	0.000482	CcSEcCtD
Hydrocortisone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.34e-05	0.000482	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.3e-05	0.00048	CcSEcCtD
Hydrocortisone—Pain—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000479	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.26e-05	0.00761	CbGpPWpGaD
Hydrocortisone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.16e-05	0.000473	CcSEcCtD
Hydrocortisone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.13e-05	0.000472	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	9.08e-05	0.00746	CbGpPWpGaD
Hydrocortisone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	9.04e-05	0.000467	CcSEcCtD
Hydrocortisone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	9.03e-05	0.000466	CcSEcCtD
Hydrocortisone—Nausea—Zidovudine—acquired immunodeficiency syndrome	9.02e-05	0.000466	CcSEcCtD
Hydrocortisone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.99e-05	0.000464	CcSEcCtD
Hydrocortisone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.99e-05	0.000464	CcSEcCtD
Hydrocortisone—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.98e-05	0.000464	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	8.98e-05	0.00737	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.94e-05	0.000461	CcSEcCtD
Hydrocortisone—Rash—Indinavir—acquired immunodeficiency syndrome	8.91e-05	0.00046	CcSEcCtD
Hydrocortisone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.9e-05	0.00046	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.87e-05	0.000458	CcSEcCtD
Hydrocortisone—Headache—Indinavir—acquired immunodeficiency syndrome	8.85e-05	0.000457	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	8.83e-05	0.00725	CbGpPWpGaD
Hydrocortisone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.83e-05	0.000456	CcSEcCtD
Hydrocortisone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.74e-05	0.000451	CcSEcCtD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—acquired immunodeficiency syndrome	8.72e-05	0.00716	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.71e-05	0.00715	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.71e-05	0.00715	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.7e-05	0.000449	CcSEcCtD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.7e-05	0.00715	CbGpPWpGaD
Hydrocortisone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.62e-05	0.000445	CcSEcCtD
Hydrocortisone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000443	CcSEcCtD
Hydrocortisone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000443	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.51e-05	0.00699	CbGpPWpGaD
Hydrocortisone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.49e-05	0.000438	CcSEcCtD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	8.48e-05	0.00697	CbGpPWpGaD
Hydrocortisone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.47e-05	0.000438	CcSEcCtD
Hydrocortisone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.45e-05	0.000436	CcSEcCtD
Hydrocortisone—Rash—Efavirenz—acquired immunodeficiency syndrome	8.42e-05	0.000435	CcSEcCtD
Hydrocortisone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.41e-05	0.000434	CcSEcCtD
Hydrocortisone—Nausea—Indinavir—acquired immunodeficiency syndrome	8.39e-05	0.000433	CcSEcCtD
Hydrocortisone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.38e-05	0.000432	CcSEcCtD
Hydrocortisone—Headache—Efavirenz—acquired immunodeficiency syndrome	8.36e-05	0.000432	CcSEcCtD
Hydrocortisone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.36e-05	0.000431	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.29e-05	0.00681	CbGpPWpGaD
Hydrocortisone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.16e-05	0.000421	CcSEcCtD
Hydrocortisone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.12e-05	0.000419	CcSEcCtD
Hydrocortisone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.08e-05	0.000417	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	8.08e-05	0.00663	CbGpPWpGaD
Hydrocortisone—Rash—Delavirdine—acquired immunodeficiency syndrome	8.05e-05	0.000416	CcSEcCtD
Hydrocortisone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.05e-05	0.000415	CcSEcCtD
Hydrocortisone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.04e-05	0.000415	CcSEcCtD
Hydrocortisone—Headache—Delavirdine—acquired immunodeficiency syndrome	8e-05	0.000413	CcSEcCtD
Hydrocortisone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000413	CcSEcCtD
Hydrocortisone—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.93e-05	0.000409	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	7.91e-05	0.0065	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.84e-05	0.00644	CbGpPWpGaD
Hydrocortisone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.81e-05	0.000403	CcSEcCtD
Hydrocortisone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.78e-05	0.000402	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	7.78e-05	0.00639	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.78e-05	0.000402	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.69e-05	0.00632	CbGpPWpGaD
Hydrocortisone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.67e-05	0.000396	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	7.63e-05	0.00627	CbGpPWpGaD
Hydrocortisone—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.59e-05	0.000392	CcSEcCtD
Hydrocortisone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.52e-05	0.000388	CcSEcCtD
Hydrocortisone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.51e-05	0.000388	CcSEcCtD
Hydrocortisone—Rash—Ritonavir—acquired immunodeficiency syndrome	7.45e-05	0.000385	CcSEcCtD
Hydrocortisone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.44e-05	0.000384	CcSEcCtD
Hydrocortisone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.42e-05	0.000383	CcSEcCtD
Hydrocortisone—Headache—Ritonavir—acquired immunodeficiency syndrome	7.4e-05	0.000382	CcSEcCtD
Hydrocortisone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.23e-05	0.000373	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	7.2e-05	0.00591	CbGpPWpGaD
Hydrocortisone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.17e-05	0.00037	CcSEcCtD
Hydrocortisone—Rash—Saquinavir—acquired immunodeficiency syndrome	7.17e-05	0.00037	CcSEcCtD
Hydrocortisone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.16e-05	0.00037	CcSEcCtD
Hydrocortisone—Headache—Saquinavir—acquired immunodeficiency syndrome	7.12e-05	0.000368	CcSEcCtD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	7.04e-05	0.00578	CbGpPWpGaD
Hydrocortisone—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.02e-05	0.000362	CcSEcCtD
Hydrocortisone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.9e-05	0.000356	CcSEcCtD
Hydrocortisone—Rash—Lamivudine—acquired immunodeficiency syndrome	6.84e-05	0.000353	CcSEcCtD
Hydrocortisone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.83e-05	0.000353	CcSEcCtD
Hydrocortisone—Headache—Lamivudine—acquired immunodeficiency syndrome	6.79e-05	0.000351	CcSEcCtD
Hydrocortisone—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.75e-05	0.000349	CcSEcCtD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	6.74e-05	0.00554	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	6.74e-05	0.00554	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.69e-05	0.0055	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.62e-05	0.00544	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—TAT—acquired immunodeficiency syndrome	6.49e-05	0.00533	CbGpPWpGaD
Hydrocortisone—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.44e-05	0.000333	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.97e-05	0.0049	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	5.84e-05	0.0048	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	5.81e-05	0.00477	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—TAT—acquired immunodeficiency syndrome	5.59e-05	0.00459	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.52e-05	0.00453	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	5.34e-05	0.00438	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.26e-05	0.00432	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.23e-05	0.0043	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	5.07e-05	0.00417	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.03e-05	0.00413	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.03e-05	0.00413	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.92e-05	0.00404	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.92e-05	0.00404	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.9e-05	0.00402	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	4.78e-05	0.00393	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.76e-05	0.00391	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.75e-05	0.0039	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	4.74e-05	0.0039	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	4.7e-05	0.00386	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.54e-05	0.00373	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.47e-05	0.00367	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.47e-05	0.00367	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	4.43e-05	0.00364	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	4.43e-05	0.00364	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	4.31e-05	0.00354	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	4.21e-05	0.00346	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	4.18e-05	0.00343	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.74e-05	0.00308	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.69e-05	0.00303	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.59e-05	0.00295	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.51e-05	0.00288	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.4e-05	0.00279	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.37e-05	0.00277	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.35e-05	0.00275	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.29e-05	0.0027	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.1e-05	0.00255	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.06e-05	0.00252	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.98e-05	0.00245	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.81e-05	0.00231	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	2.79e-05	0.00229	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	2.78e-05	0.00228	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	2.75e-05	0.00226	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.64e-05	0.00217	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.64e-05	0.00217	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	2.6e-05	0.00214	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.57e-05	0.00211	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.54e-05	0.00209	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	2.46e-05	0.00202	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	2.44e-05	0.00201	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.36e-05	0.00194	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	2.34e-05	0.00192	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.31e-05	0.0019	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.19e-05	0.0018	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—TNF—acquired immunodeficiency syndrome	2.11e-05	0.00173	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.01e-05	0.00165	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	1.99e-05	0.00163	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.98e-05	0.00162	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.95e-05	0.0016	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.82e-05	0.00149	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.81e-05	0.00149	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.77e-05	0.00145	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	1.72e-05	0.00142	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—IL6—acquired immunodeficiency syndrome	1.7e-05	0.0014	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	1.69e-05	0.00139	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.68e-05	0.00138	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.5e-05	0.00123	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.47e-05	0.00121	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	1.47e-05	0.0012	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.37e-05	0.00113	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.31e-05	0.00107	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.28e-05	0.00105	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ALB—acquired immunodeficiency syndrome	1.13e-05	0.00093	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000859	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000854	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.03e-05	0.000849	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ALB—acquired immunodeficiency syndrome	9.75e-06	0.000801	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	9.25e-06	0.00076	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	8.31e-06	0.000683	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	7.86e-06	0.000646	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.75e-06	0.000554	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.14e-06	0.000505	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	6.11e-06	0.000502	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.59e-06	0.000459	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	4.84e-06	0.000398	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	4.8e-06	0.000394	CbGpPWpGaD
Hydrocortisone—Prednisone—ALB—acquired immunodeficiency syndrome	3.95e-06	0.289	CrCbGaD
Hydrocortisone—Norethindrone—ALB—acquired immunodeficiency syndrome	3.89e-06	0.284	CrCbGaD
Hydrocortisone—Methyltestosterone—ALB—acquired immunodeficiency syndrome	3.69e-06	0.27	CrCbGaD
Hydrocortisone—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	3.47e-06	0.000285	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	3e-06	0.000247	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	2.62e-06	0.000215	CbGpPWpGaD
Hydrocortisone—Testosterone—ALB—acquired immunodeficiency syndrome	2.14e-06	0.157	CrCbGaD
Hydrocortisone—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.61e-06	0.000132	CbGpPWpGaD
